As expected, both BIM and PUMA peptides depolarized all of the leukemic cells tested except for those lacking BAX and BAK, further illustrating that the DKO p185+ B-ALL cells are defective in the core apoptotic pathway (Figure 2F). This evidence concerns the gene BCL2L11 and acute lymphoblastic leukemia.